Valuation: Eurofins Scientific SE

Market Cap 13.22B 14.89B 12.37B 11.21B 21.17B 1,435B 21.33B 149B 57.78B 732B 55.89B 54.69B 2,354B P/E 2026 *
25.4x
P/E 2027 * 20.1x
Enterprise Value 16.66B 18.77B 15.59B 14.13B 26.69B 1,809B 26.89B 187B 72.84B 923B 70.46B 68.95B 2,967B EV / Sales 2026 *
2.21x
EV / Sales 2027 * 2.05x
Free-Float
60.39%
Yield 2026 *
1.05%
Yield 2027 * 1.19%
Manager TitleAgeSince
Chief Executive Officer 63 1986-12-31
Director of Finance/CFO - 2014-12-31
Corporate Officer/Principal 54 2019-09-30
Director TitleAgeSince
Chairman 63 1986-12-31
Director/Board Member 60 2014-12-31
Director/Board Member 60 1989-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-1.07%-4.59% - - 14.89B
+4.16%+4.16%+49.37%+94.17% 74.69B
+2.76%-1.60%+22.80%+78.53% 58.81B
+0.24%-1.34%+3.41%+34.31% 48.45B
-3.76%-2.25%+329.09%+698.20% 42.84B
-2.30%-3.35%+26.81%+30.88% 42.79B
+0.31%-0.68%+5.30%+108.64% 41.25B
-0.11%+1.96%+9.19%+52.66% 31.13B
-1.81%+1.43%+35.36%+26.61% 30.28B
-1.96%-2.88%-8.97%-13.92% 24.05B
Average -0.35%-0.78%+52.48%+123.34% 43.81B
Weighted average by Cap. +0.29%-0.92%+55.29%+129.70%

Financials

2026 *2027 *
Net sales 7.53B 8.49B 7.05B 6.39B 12.07B 818B 12.16B 84.68B 32.93B 417B 31.86B 31.17B 1,342B 7.94B 8.95B 7.43B 6.74B 12.72B 862B 12.82B 89.27B 34.72B 440B 33.58B 32.86B 1,414B
Net income 531M 598M 497M 450M 850M 57.65B 857M 5.97B 2.32B 29.41B 2.24B 2.2B 94.55B 660M 743M 617M 560M 1.06B 71.64B 1.06B 7.41B 2.88B 36.55B 2.79B 2.73B 117B
Net Debt 3.44B 3.88B 3.22B 2.92B 5.52B 374B 5.56B 38.72B 15.06B 191B 14.57B 14.25B 614B 3.1B 3.49B 2.9B 2.63B 4.97B 337B 5B 34.84B 13.55B 172B 13.11B 12.83B 552B
Projected Income Statement - Annual - Eurofins Scientific SE
Logo Eurofins Scientific SE
Eurofins Scientific SE is one of the world's leading providers of bio-analytical services. The group's services are intended to validate the safety, authenticity, origin, identity, and purity of biological substances contained in the environment (water, air, soil, etc.) and in food, pharmaceutical, cosmetic, and hygiene products. At the end of 2025, Eurofins Scientific SE owned a portfolio of over 200,000 analytical methods and had 950 laboratories located throughout the world. Net sales are distributed geographically as follows: Europe (52,5%), North America (36.8%) and other (10.7%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
Ratings Surperformance© - Eurofins Scientific SE
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
76.14EUR
Average target price
72.29EUR
Spread / Average Target
-5.05%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Eurofins Scientific SE